Participants were divided equally and randomly into the control (placebo + statin) group and the test group (icosapent + statin) and the number of cardiovascular disease-related events were monitored. The test group had a significantly reduced number of cardiovascular events.
Read more
N. R. Gough, Statin Plus Icosapent, A Recipe for Reducing Cardiovascular Disease Risk. BioSerendipity (29 October 2019) https://www.bioserendipity.com/statin-plus-icosapent,-a-recipe-for-reducing-cardiovascular-disease-risk/